BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 17367582)

  • 1. Unified Huntington's disease rating scale: clinical practice and a critical approach.
    Klempír J; Klempírova O; Spacková N; Zidovská J; Roth J
    Funct Neurol; 2006; 21(4):217-21. PubMed ID: 17367582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.
    Mov Disord; 1996 Mar; 11(2):136-42. PubMed ID: 8684382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between CAG repeat length and clinical progression in Huntington's disease.
    Ravina B; Romer M; Constantinescu R; Biglan K; Brocht A; Kieburtz K; Shoulson I; McDermott MP
    Mov Disord; 2008 Jul; 23(9):1223-7. PubMed ID: 18512767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A shortened version of the motor section of the Unified Huntington's Disease Rating Scale.
    Siesling S; Zwinderman AH; van Vugt JP; Kieburtz K; Roos RA
    Mov Disord; 1997 Mar; 12(2):229-34. PubMed ID: 9087982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of simple movements reflects impairment in Huntington's disease.
    Saft C; Andrich J; Meisel NM; Przuntek H; Müller T
    Mov Disord; 2006 Aug; 21(8):1208-12. PubMed ID: 16700032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unified Huntington's disease rating scale: a follow up.
    Siesling S; van Vugt JP; Zwinderman KA; Kieburtz K; Roos RA
    Mov Disord; 1998 Nov; 13(6):915-9. PubMed ID: 9827615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of psychopathology in Huntington's disease: the critical role of caregivers.
    van Duijn E; Giltay EJ; Zitman FG; Roos RA; van der Mast RC
    J Nerv Ment Dis; 2010 May; 198(5):329-33. PubMed ID: 20458193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Huntington chorea. Clinical correlations and preliminary neuropsychological data].
    Fragassi NA; Stanzione M; Angelini R; Di Maio L
    Acta Neurol (Napoli); 1992; 14(4-6):530-6. PubMed ID: 1293994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex movement behaviour and progression of Huntington's disease.
    Andrich J; Saft C; Ostholt N; Müller T
    Neurosci Lett; 2007 Apr; 416(3):272-4. PubMed ID: 17321683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers.
    Foroud T; Siemers E; Kleindorfer D; Bill DJ; Hodes ME; Norton JA; Conneally PM; Christian JC
    Ann Neurol; 1995 May; 37(5):657-64. PubMed ID: 7755361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study using nabilone for symptomatic treatment in Huntington's disease.
    Curtis A; Mitchell I; Patel S; Ives N; Rickards H
    Mov Disord; 2009 Nov; 24(15):2254-9. PubMed ID: 19845035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of neuropathological severity in 100 patients with Huntington's disease.
    Rosenblatt A; Abbott MH; Gourley LM; Troncoso JC; Margolis RL; Brandt J; Ross CA
    Ann Neurol; 2003 Oct; 54(4):488-93. PubMed ID: 14520661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease.
    Reilmann R; Bohlen S; Klopstock T; Bender A; Weindl A; Saemann P; Auer DP; Ringelstein EB; Lange HW
    Mov Disord; 2010 Oct; 25(13):2195-202. PubMed ID: 20645403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradykinesia in Huntington's disease. A prospective, follow-up study.
    García Ruiz PJ; Hernández J; Cantarero S; Bartolomé M; Sánchez Bernardos V; García de Yébenez J
    J Neurol; 2002 Apr; 249(4):437-40. PubMed ID: 11967649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Dec; 28(14):1995-2001. PubMed ID: 24123464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Huntington disease: clinical and genetic study in a Spanish population].
    Solís Pérez MP; Palau Martínez F; Burguera Hernández JA; Salazar Cifré A
    Neurologia; 1995 Nov; 10(9):362-6. PubMed ID: 8554791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical measurement of mobility and balance impairments in Huntington's disease: validity and responsiveness.
    Rao AK; Muratori L; Louis ED; Moskowitz CB; Marder KS
    Gait Posture; 2009 Apr; 29(3):433-6. PubMed ID: 19111470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological deterioration over time in patients with Huntington's disease.
    Lefaucheur JP; Ménard-Lefaucheur I; Maison P; Baudic S; Cesaro P; Peschanski M; Bachoud-Lévi AC
    Mov Disord; 2006 Sep; 21(9):1350-4. PubMed ID: 16721731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.
    Ribaï P; Nguyen K; Hahn-Barma V; Gourfinkel-An I; Vidailhet M; Legout A; Dodé C; Brice A; Dürr A
    Arch Neurol; 2007 Jun; 64(6):813-9. PubMed ID: 17562929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number.
    Gómez-Ansón B; Alegret M; Muñoz E; Monté GC; Alayrach E; Sánchez A; Boada M; Tolosa E
    Parkinsonism Relat Disord; 2009 Mar; 15(3):213-9. PubMed ID: 18632301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.